SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-15-000013
Filing Date
2015-08-12
Accepted
2015-08-12 16:09:26
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imdz630201510-q.htm 10-Q 872870
2 EXHIBIT 10.1 ex101rickeyseparation.htm EX-10.1 52936
3 EXHIBIT 31.1 ex311imdz2015q2.htm EX-31.1 7600
4 EXHIBIT 31.2 ex312imdz2015q2.htm EX-31.2 7981
5 EXHIBIT 32.1 ex321imdz2015q2.htm EX-32.1 4822
6 EXHIBIT 32.2 ex322imdz2015q2.htm EX-32.2 5072
  Complete submission text file 0001437786-15-000013.txt   3633890

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imdz-20150630.xml EX-101.INS 553507
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20150630.xsd EX-101.SCH 30123
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20150630_cal.xml EX-101.CAL 42531
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20150630_def.xml EX-101.DEF 126507
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20150630_lab.xml EX-101.LAB 406322
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20150630_pre.xml EX-101.PRE 231505
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 151047121
SIC: 2834 Pharmaceutical Preparations